[PDF] Management of drug-induced immune and secondary autoimmune, haemolytic anaemia

British Society for Haematology
British Society for Haematology
Publication date:
10 February 2017


Guideline aims to provide healthcare professionals with guidance on managing secondary autoimmune haemolytic anaemia (AIHA). Serologically, cases are divided into warm, cold or mixed AIHA. Drug induced cases make up about 10% of total when included in series of patients with AIHA